000 01356 a2200385 4500
005 20250516055835.0
264 0 _c20120301
008 201203s 0 0 eng d
022 _a1746-0921
024 7 _a10.2217/fmb.11.88
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBarrett, Michael P
245 0 0 _aDrug resistance in human African trypanosomiasis.
_h[electronic resource]
260 _bFuture microbiology
_cSep 2011
300 _a1037-47 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAnimals
650 0 4 _aDrug Resistance
_xgenetics
650 0 4 _aEflornithine
_xpharmacokinetics
650 0 4 _aHumans
650 0 4 _aMembrane Transport Proteins
_xmetabolism
650 0 4 _aNifurtimox
_xpharmacokinetics
650 0 4 _aPentamidine
_xmetabolism
650 0 4 _aProtozoan Proteins
_xmetabolism
650 0 4 _aTreatment Failure
650 0 4 _aTrypanocidal Agents
_xpharmacokinetics
650 0 4 _aTrypanosoma
_xdrug effects
650 0 4 _aTrypanosomiasis, African
_xdrug therapy
700 1 _aVincent, Isabel M
700 1 _aBurchmore, Richard J S
700 1 _aKazibwe, Anne J N
700 1 _aMatovu, Enock
773 0 _tFuture microbiology
_gvol. 6
_gno. 9
_gp. 1037-47
856 4 0 _uhttps://doi.org/10.2217/fmb.11.88
_zAvailable from publisher's website
999 _c21194947
_d21194947